IVOS Medical Joins NIH's C3i Program To Accelerate Commercialization Of BOSS G4TM Airway Management Technology
IRVINE, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- IVOS Medical, Inc ., a medical device startup specializing in airway management solutions, today announced that its BOSS G4TM Video Laryngoscope Sleeve has been selected for the NIH Concept to Clinic: Commercializing Innovation (C3i) Program-an intensive incubator that advances biomedical technologies and entrepreneurs from concept to clinical readiness.
“Being selected for the C3i Program represents a pivotal milestone in our journey to bring the IVOS BOSS to patients,” said Gabriel Punsalan, MS, CRNA, CEO and Co-Founder of IVOS Medical.“The NIH's mentorship and commercialization frameworks will sharpen our strategy and accelerate our mission to transform the standard of care in airway management.”
About the C3i Program
The NIH C3i incubator provides a hands-on, accelerated experience for biomedical innovators bringing new technologies to patients. Participants focus on understanding unmet needs, defining stakeholder priorities, navigating regulatory and IP considerations, and developing actionable commercialization plans with guidance from expert industry and NIH mentors.
About the IVOS BOSS G4TM
The IVOS BOSS G4 (Breathing Optimization and Suction System) is an innovative video laryngoscope sleeve that integrates continuous, targeted suction and independent oxygen delivery. This combination rapidly clears aspirate and debris while maintaining a clear tracheal view-even in heavily soiled airways-enabling precise tube placement and higher first-pass success rates. By reducing oxygen deprivation during intubation, the BOSS G4 enhances patient safety and improves outcomes across emergency, perioperative, and critical care settings.
About IVOS Medical
IVOS Medical is a medical device company advancing airway management technology, particularly for challenging intubations. Its flagship product, the patented Breathing Optimization and Suction System (BOSSTM), enhances critical intubation success through video laryngoscopy. Founded by clinicians with extensive airway management experience, the company addresses the challenges health care providers face during critical and emergency intubations. Supported by over $2 million in non-dilutive NIH SBIR funding and exclusively licensed from UC Irvine, IVOS Medical remains focused on elevating patient safety and healthcare efficiency through better intubation tools.
For more information, visit or email ... .
For media inquiries, please contact: ...
The IVOS BOSS G4 is a trademark of IVOS MEDICAL, Inc. All other products or service names are the property of their respective owners.
CONTACT: Media Contact: Joe Waldygo TopSpin Communications E: ... C: 480-363-8774 Company Contact: Gabriel Punsalan, CEO & Co-Founder IVOS Medical, Inc. E: ... P: 949-357-0369

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Japan Buy Now Pay Later Market Size To Surpass USD 145.5 Billion By 2033 CAGR Of 22.23%
- BTCC Summer Festival 2025 Unites Japan's Web3 Community
- GCL Subsidiary, 2Game Digital, Partners With Kucoin Pay To Accept Secure Crypto Payments In Real Time
- Smart Indoor Gardens Market Growth: Size, Trends, And Forecast 20252033
- Nutritional Bar Market Size To Expand At A CAGR Of 3.5% During 2025-2033
- Pluscapital Advisor Empowers Traders To Master Global Markets Around The Clock
Comments
No comment